BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

458 related articles for article (PubMed ID: 11584300)

  • 21. Mitogenic signalling and the p16INK4a-Rb pathway cooperate to enforce irreversible cellular senescence.
    Takahashi A; Ohtani N; Yamakoshi K; Iida S; Tahara H; Nakayama K; Nakayama KI; Ide T; Saya H; Hara E
    Nat Cell Biol; 2006 Nov; 8(11):1291-7. PubMed ID: 17028578
    [TBL] [Abstract][Full Text] [Related]  

  • 22. p16 and ARF: activation of teenage proteins in old age.
    Satyanarayana A; Rudolph KL
    J Clin Invest; 2004 Nov; 114(9):1237-40. PubMed ID: 15520854
    [TBL] [Abstract][Full Text] [Related]  

  • 23. p53-Dependent and -independent functions of the Arf tumor suppressor.
    Sherr CJ; Bertwistle D; DEN Besten W; Kuo ML; Sugimoto M; Tago K; Williams RT; Zindy F; Roussel MF
    Cold Spring Harb Symp Quant Biol; 2005; 70():129-37. PubMed ID: 16869746
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genomic instability, mutations and expression analysis of the tumour suppressor genes p14(ARF), p15(INK4b), p16(INK4a) and p53 in actinic keratosis.
    Kanellou P; Zaravinos A; Zioga M; Stratigos A; Baritaki S; Soufla G; Zoras O; Spandidos DA
    Cancer Lett; 2008 Jun; 264(1):145-61. PubMed ID: 18331779
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased gene dosage of Ink4a/Arf results in cancer resistance and normal aging.
    Matheu A; Pantoja C; Efeyan A; Criado LM; Martín-Caballero J; Flores JM; Klatt P; Serrano M
    Genes Dev; 2004 Nov; 18(22):2736-46. PubMed ID: 15520276
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Co-transfection of p16(INK4a) and p53 genes into the K562 cell line inhibits cell proliferation.
    Rui HB; Su JZ
    Haematologica; 2002 Feb; 87(2):136-42. PubMed ID: 11836163
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ink4a/Arf links senescence and aging.
    Sharpless NE
    Exp Gerontol; 2004; 39(11-12):1751-9. PubMed ID: 15582292
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The INK4a/ARF locus and melanoma.
    Sharpless E; Chin L
    Oncogene; 2003 May; 22(20):3092-8. PubMed ID: 12789286
    [TBL] [Abstract][Full Text] [Related]  

  • 29. E2F1 suppresses skin carcinogenesis via the ARF-p53 pathway.
    Russell JL; Weaks RL; Berton TR; Johnson DG
    Oncogene; 2006 Feb; 25(6):867-76. PubMed ID: 16205640
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of retinoblastoma protein and P16 proteins in classic Hodgkin lymphoma: relationship with expression of p53 and presence of Epstein-Barr virus in the regulation of cell growth and death.
    Kim LH; Peh SC; Poppema S
    Hum Pathol; 2006 Jan; 37(1):92-100. PubMed ID: 16360421
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Alteration of the p14(ARF) gene and p53 status in human hepatocellular carcinomas.
    Ito T; Nishida N; Fukuda Y; Nishimura T; Komeda T; Nakao K
    J Gastroenterol; 2004; 39(4):355-61. PubMed ID: 15168247
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Frequent alteration of p16(INK4a)/p14(ARF) and p53 pathways in the round cell component of myxoid/round cell liposarcoma: p53 gene alterations and reduced p14(ARF) expression both correlate with poor prognosis.
    Oda Y; Yamamoto H; Takahira T; Kobayashi C; Kawaguchi K; Tateishi N; Nozuka Y; Tamiya S; Tanaka K; Matsuda S; Yokoyama R; Iwamoto Y; Tsuneyoshi M
    J Pathol; 2005 Dec; 207(4):410-21. PubMed ID: 16177957
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Mutations of several tumor suppressor genes in primary retinoblastoma].
    Huang Q; Tao Y; Yandell DW
    Zhonghua Zhong Liu Za Zhi; 1999 Jan; 21(1):10-2. PubMed ID: 11776785
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fine-mapping loss of gene architecture at the CDKN2B (p15INK4b), CDKN2A (p14ARF, p16INK4a), and MTAP genes in head and neck squamous cell carcinoma.
    Worsham MJ; Chen KM; Tiwari N; Pals G; Schouten JP; Sethi S; Benninger MS
    Arch Otolaryngol Head Neck Surg; 2006 Apr; 132(4):409-15. PubMed ID: 16618910
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Consistent inactivation of p19(Arf) but not p15(Ink4b) in murine myeloid cells transformed in vivo by deregulated c-Myc.
    Haviernik P; Schmidt M; Hu X; Wolff L
    Oncogene; 2003 Mar; 22(11):1600-10. PubMed ID: 12642863
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mice with alterations in both p53 and Ink4a/Arf display a striking increase in lung tumor multiplicity and progression: differential chemopreventive effect of budesonide in wild-type and mutant A/J mice.
    Wang Y; Zhang Z; Kastens E; Lubet RA; You M
    Cancer Res; 2003 Aug; 63(15):4389-95. PubMed ID: 12907609
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mouse p10, an alternative spliced form of p15INK4b, inhibits cell cycle progression and malignant transformation.
    Pérez de Castro I; Benet M; Jiménez M; Alzabin S; Malumbres M; Pellicer A
    Cancer Res; 2005 Apr; 65(8):3249-56. PubMed ID: 15833857
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Retinoblastoma pathway defects show differential ability to activate the constitutive DNA damage response in human tumorigenesis.
    Tort F; Bartkova J; Sehested M; Orntoft T; Lukas J; Bartek J
    Cancer Res; 2006 Nov; 66(21):10258-63. PubMed ID: 17079443
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ubiquitination of, and sumoylation by, the Arf tumor suppressor.
    den Besten W; Kuo ML; Tago K; Williams RT; Sherr CJ
    Isr Med Assoc J; 2006 Apr; 8(4):249-51. PubMed ID: 16671360
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of p15 and p15.5 products in neuroendocrine lung tumours: relationship with p15(INK4b) methylation status.
    Chaussade L; Eymin B; Brambilla E; Gazzeri S
    Oncogene; 2001 Oct; 20(45):6587-96. PubMed ID: 11641784
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.